Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Don Kania, Ph.D., has been appointed to the Board of Directors of Aldevron, a global provider of plasmid DNA manufacturing, protein production and antibody discovery services.
read more
Centogene has entered into an agreement with Aldeyra Therapeutics, a biotechnology company developing medicines to improve the lives of patients with immune-mediated diseases.
read more
MedReleaf and BioPharma Services have entered into an exclusive agreement to conduct clinical research for cannabis and cannabis derived products.
read more
Ipsen announced a global licensing and joint development agreement for a pre-clinical oncology drug candidate discovered by researchers in MD Anderson’s Institute for Applied Cancer Science (IACS).
read more
PerkinElmer has acquired Shanghai Spectrum Instruments.
read more
Samsung BioLogics announced today that a third monoclonal antibody Drug Substance has been licensed by the FDA for its second plant.
read more
Avara has agreed to acquire the largest sterile manufacturing facility for injectable medicines in Canada from a global pharmaceutical company, as part of a continuing expansion of its global footprint.
read more
Bicycle Therapeutics announced it is expanding its collaboration with AstraZeneca to include additional targets in respiratory and cardio-metabolic diseases.
read more
Fujifilm has announced the extension of its gene therapy and viral vaccine Fill/Finish capabilities to provide services in support of late phase candidates and commercial supply.
read more
Gary Tanner, a former executive at Valeant Pharmaceuticals, and Andrew Davenport, the former CEO of Philidor Rx Services, for engaging in a multimillion-dollar kickback scheme.
read more
Tanner Pharma Group has announced the signing of a distribution agreement with Partner Therapeutics, (PTx), an integrated biopharmaceutical company.
read more
Stellar Biotechnologies announced that third-party trial results have demonstrated that the company's KLH manufacturing methods achieve robust viral clearance.
read more
AGC Biologics will supply bulk drug substance for the launch of Portola Pharmaceuticals' Andexxa [coagulation factor Xa (recombinant), inactivated-zhzo].
read more
Recipharm has established a dedicated taskforce to manage the potential impact of Brexit on its organization.
read more
Oncternal Therapeutics announced a clinical supply arrangement with Pharmacyclics.
read more